Focus on Melanoma Meeting 2023

Friday 13th October 2023

Organised by: Professor Rowan Pritchard-Jones, Consultant Plastic Reconstructive Surgeon, and Executive Medical Director, Cheshire & Merseyside Integrated Care System

Location: The Royal College of Physicians, London

Registration for this event is now open

Friday, 13th October 20239:00 am – 5:00 pm

The year’s Focus on Melanoma meeting has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 5 category 1 (external) CPD credit(s).The British Association of Plastic, Reconstructive and Aesthetic Surgeons have awarded up to 5.5 CME credits. The Royal College of Surgeons of England has awarded up to 6 CPD points.

Poster abstracts to be submitted by Sunday 17th September 2023 (250 words maximum) to jenn@melanomafocus.org

Registration

Member Rates


Registration fee
ConsultantOpen Form£219
Other Clinician/AHPOpen Form£159
Nurse/Medical StudentOpen Form£89

Non-Member Rates


Registration fee
ConsultantOpen Form£269
Other Clinician/AHPOpen Form£189
Nurse/Medical StudentOpen Form£99
IndustryOpen Form£299

Programme

09:00-09:55

PIERRE FABRE SPONSORED PROMOTIONAL BREAKFAST SYMPOSIUM:

 

Decision-making in BRAF-mutant metastatic melanoma: an interactive review of case studies

 

Chair: Dr Pippa Corrie, Consultant Medical Oncologist, Cambridge University Hospitals NHS Foundation Trust

– Dr Ricky Frazer, Consultant Medical Oncologist, Velindre Cancer Centre

– Dr Matthew Wheater, Consultant Medical Oncologist, University Hospital Southampton NHS Foundation Trust

 

This promotional session is fully organised and funded by Pierre Fabre. Pierre Fabre products will be discussed at this meeting.

10:00-10:05

Welcome/Introductions

-Dr Mark Harries, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust and Chairman of Melanoma Focus

-Professor Rowan Pritchard-Jones, Consultant Plastic Reconstructive Surgeon, and Executive Medical Director, Cheshire & Merseyside Integrated Care System

10:05-10:15

Melanoma Focus: Achievements and Plans

Dr Mark Harries and Susanna Daniels

10:15-11:35

Session 1:  Neoadjuvant treatment – Medical & Surgical Collaboration

Chair: Professor Marc Moncrieff, Consultant Plastic Reconstructive Surgeon, Norfolk & Norwich University Hospitals NHS Foundation Trust

10:15-10:45

Neoadjuvant treatment

Professor James Larkin, Consultant Medical Oncologist, Royal Marsden Hospital, London

10:45-11:15

Addressing Surgical concerns of Neoadjuvant Treatment

Dr Vernon Sondak, Chair of the Department of Cutaneous Oncology, H Lee Moffitt Cancer Centre and Research Institute, Tampa, Florida

11:15-11:35

Q&A (20 minutes)

11:35-12:00

Break

12:00-13:00

Session 2: High risk primary disease and options beyond the obvious

Chair: Rowan Pritchard-Jones, Consultant Plastic Reconstructive Surgeon, and Executive Medical Director, Cheshire & Merseyside Integrated Care System

12:00-12:30

High risk primary melanoma management

-Mr Myles Smith, General Surgeon and Surgical Oncologist, Royal Marsden Hospital, London

-Professor James Larkin, Consultant Medical Oncologist, Royal Marsden Hospital, London

12:30 - 12:50

Neoadjuvant ECT

Dr Luca Campana, General Surgical Oncologist, Manchester Royal Infirmary

12:50-13:00

Q&A (10 minutes)

13:00-14:00

Lunch

14:00-14:50

Session 3:  Panel Discussion:  Does SLNB remain a meaningful staging procedure?

Chair: Rowan Pritchard- Jones, Consultant Plastic Reconstructive Surgeon, and Executive Medical Director, Cheshire & Merseyside Integrated Care System

 

-Dr Anna Olsson-Brown, Consultant in Medical Oncology and Immunotherapy Service Lead, Clatterbridge Cancer Centre, Liverpool

 

-Professor Marc Moncrieff, Consultant Plastic Reconstructive Surgeon, Norfolk & Norwich University Hospitals NHS Foundation Trust

 

-Dr Vernon Sondak, Chair of the Department of Cutaneous Oncology, H Lee Moffitt Cancer Centre and Research Institute, Tampa, Florida

14:50-15:35

The Professor Martin Gore CBE Memorial Lecture:

 

Introduction – Dr Mark Harries, Consultant Medical Oncologist, Guy’s and St Thomas’ NHS Foundation Trust and Chairman of Melanoma Focus

 

Multidisciplinary Management of Melanoma: Past, Present, and Future 

 

Professor Charles Balch, Department of Surgical Oncology – Research, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas

15:35-15:45

Post NCRI- The UK Skin Cancer Clinical Trials Group

Dr Brent O’Carrigan, Consultant Medical Oncologist, Cambridge University Hospitals NHS Trust

15:45-16:55

Session 5:  MDT:  Locally Advanced Disease

Chair: Mr Howard Peach, Consultant, Consultant Plastic Surgeon, Leeds Teaching Hospitals NHS Trust

 

– Dr Vernon Sondak, Chair of the Department of Cutaneous Oncology, H Lee Moffitt Cancer Centre and Research Institute, Tampa, Florida

 

-Dr Anna Olsson-Brown, Consultant in Medical Oncology and Immunotherapy Service Lead, Clatterbridge Cancer Centre, Liverpool

 

-Dr Luca Campana, General Surgical Oncologist, Manchester Royal Infirmary

 

-Mr Myles Smith, General Surgeon and Surgical Oncologist, Royal Marsden Hospital, London

 

-Professor Catherine Harwood, Consultant Dermatologist, Barts Health NHS Trust

16:55-17:00

Close

Professor Rowan Pritchard-Jones and Dr Mark Harries